1. Market Research
  2. > Healthcare
  3. > Pathology
  4. > Chronic Disease Market Trends
  5. > Orthopaedics Business News APRIL 2016

Orthopaedics Business News APRIL 2016

  • April 2016
  • -
  • Espicom Business Intelligence
  • -
  • 16 pages

Industry Trend Analysis - J&J Medical Devices Segment Remains Muted
Industry Brief - Vivex/Arthrex Enter Additional Partnership
Industry Trend Analysis - Stryker's FY16 M&A Drive Supports Strategic Expansion
Industry Brief - DJO/Zimmer-Biomet Settle Bone-Growth Stimulator Suit
Industry Brief - Amedica Signs Agreement For Implant Distribution In China
Industry Trend Analysis - Stryker Justifies Bullish Outlook With Strong Q116
Industry Brief - Orthopaedic Devices 510(k) Clearances - March 2016
Industry Brief - Anika Therapeutics Secures CE Marking For Cingal To Treat Osteoarthritis Knee Pain
Industry Trend Analysis - The Rise Of Value-Based Care: What, Why, When, Where And How?
Industry Brief - US Launch Of Premia Spine ProMIS Screw Fixation System
Industry Brief - Opticage LIF Implants Range Launched In US
Industry Brief - FDA Clears K2M's Mesa/Denali Mini Systems To Treat Posterior Cervical Spine
Industry Trend Analysis - Operational Excellence Will Be Paramount To ConforMIS' Future Success
Industry Trend Analysis - Latest Infuse Allegations Highlight Wider Industry Issues
Industry Brief - Aurora Spine Secures US Patent Covering ZIP ISP Range
Industry Brief - First Clinical Applications Of Gruve Anterior Cervical Plate System Reported
Industry Brief - Amedica 3D Prints Silicon Nitride For Medical Applications
Industry Brief - SI-BONE Reports Publication Of iFuse Implant System Trial Results
Industry Brief - Orthopaedics Conferences - April 2016

Table Of Contents

Orthopaedics Business News APRIL 2016

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation

Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation

  • $ 6995
  • Industry report
  • November 2016
  • by GBI Research

Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation Summary Asthma is a chronic condition affecting ...

Frontier Pharma: Type 2 Diabetes Mellitus - GPCRs and Protein Kinases Dominate Pipeline, with Most Promising First-in-Class Targets Demonstrating Potential Disease-Modifying Effects

Frontier Pharma: Type 2 Diabetes Mellitus - GPCRs and Protein Kinases Dominate Pipeline, with Most Promising First-in-Class Targets Demonstrating Potential Disease-Modifying Effects

  • $ 6995
  • Industry report
  • December 2016
  • by GBI Research

Frontier Pharma: Type 2 Diabetes Mellitus - GPCRs and Protein Kinases Dominate Pipeline, with Most Promising First-in-Class Targets Demonstrating Potential Disease-Modifying Effects Summary Type 2 diabetes ...

Bovine Respiratory Disease Treatment Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024

Bovine Respiratory Disease Treatment Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024

  • $ 5795
  • Industry report
  • October 2016
  • by Transparency Market Research

Global Bovine Respiratory Disease Treatment Market: Overview Bovine respiratory disease (BRD) is a multifactorial and complex disorder caused due to combination of more than one microbial pathogens, impaired ...


ref:plp2016

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.